Literature DB >> 15187149

An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family.

Stefanie Ernst1, Carsten Lange, Andreas Wilbers, Verena Goebeler, Volker Gerke, Ursula Rescher.   

Abstract

The human N-formyl peptide receptor (FPR) is a key modulator of chemotaxis directing granulocytes toward sites of bacterial infections. FPR is the founding member of a subfamily of G protein-coupled receptors thought to function in inflammatory processes. The other two members, FPR-like (FPRL)1 and FPRL2, have a greatly reduced affinity for bacterial peptides or do not bind them at all, with FPRL2 being considered an orphan receptor so far. In this study we show that a peptide derived from the N-terminal domain of the anti-inflammatory protein annexin 1 (lipocortin 1) can activate all three FPR family members at similar concentrations. The annexin 1 peptide initiates chemotactic responses in human monocytes that express all three FPR family members and also desensitizes the cells toward subsequent stimulation with bacterial peptide agonists. Experiments using HEK 293 cells stably expressing a single FPR family member reveal that all three receptors can be activated and desensitized by the N-terminal annexin 1 peptide. These observations identify the annexin 1 peptide as the first endogenous ligand of FPRL2 and indicate that annexin 1 participates in regulating leukocyte emigration into inflamed tissue by activating and desensitizing different receptors of the FPR family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187149     DOI: 10.4049/jimmunol.172.12.7669

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Impaired phagocytic mechanism in annexin 1 null macrophages.

Authors:  Simon Yona; Sigrid E M Heinsbroek; Leanne Peiser; Siamon Gordon; Mauro Perretti; Roderick J Flower
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

Review 2.  New methods for researching accessory proteins.

Authors:  Steven M Foord; Simon D Topp; Marco Abramo; Joanna D Holbrook
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 3.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

4.  Annexin A1 regulates intestinal mucosal injury, inflammation, and repair.

Authors:  Brian A Babbin; Mike G Laukoetter; Porfirio Nava; Stefan Koch; Winston Y Lee; Christopher T Capaldo; Eric Peatman; Eric A Severson; Roderick J Flower; Mauro Perretti; Charles A Parkos; Asma Nusrat
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions.

Authors:  Josh C Woloszynek; Ying Hu; Christine T N Pham
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

6.  4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.

Authors:  Liliya N Kirpotina; Igor A Schepetkin; Andrei I Khlebnikov; Olga I Ruban; Yunjun Ge; Richard D Ye; Douglas J Kominsky; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2017-07-08       Impact factor: 5.858

Review 7.  Molecular biology for formyl peptide receptors in human diseases.

Authors:  Yongsheng Li; Duyun Ye
Journal:  J Mol Med (Berl)       Date:  2013-02-13       Impact factor: 4.599

8.  Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.

Authors:  Giovanna Leoni; Ashfaqul Alam; Philipp-Alexander Neumann; J David Lambeth; Guangjie Cheng; James McCoy; Roland S Hilgarth; Kousik Kundu; Niren Murthy; Dennis Kusters; Chris Reutelingsperger; Mauro Perretti; Charles A Parkos; Andrew S Neish; Asma Nusrat
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

9.  CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features.

Authors:  Lauren A Geary; Kevin A Nash; Helty Adisetiyo; Mengmeng Liang; Chun-Peng Liao; Joseph H Jeong; Ebrahim Zandi; Pradip Roy-Burman
Journal:  Mol Cancer Res       Date:  2014-01-24       Impact factor: 5.852

10.  Downstream gene activation of the receptor ALX by the agonist annexin A1.

Authors:  Derek Renshaw; Trinidad Montero-Melendez; Jesmond Dalli; Ahmad Kamal; Vincenzo Brancaleone; Fulvio D'Acquisto; Giuseppe Cirino; Mauro Perretti
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.